Acridine and Acridone Derivatives, Anticancer Properties and Synthetic Methods: Where Are We Now?

E-ISSN： 1875-5992|7|2|139-169

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.7, Iss.2, 2007-01, pp. : 139-169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthetic Mono/di-halogenated Coumarin Derivatives and Their Anticancer Properties

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 2, 2017-01 ,pp. : 276-285

Bentham Science Publishers

Access to resources Recommend Favorite

Gastroenteropancreatic neuroendocrine tumors. Where are we now?

By Castellano Daniel

Cancer and Metastasis Reviews, Vol. 30, Iss. 1, 2011-03 ,pp. : 1-1

Springer Publishing Company

Access to resources Recommend Favorite

Intraductal Papillary Mucinous Tumors of the Pancreas: Where Are We Now?

International Journal of Gastrointestinal Cancer, Vol. 27, Iss. 3, 2000-06 ,pp. : 181-194

Humana Press, Inc

Access to resources Recommend Favorite

A critical review on HE4 performance in endometrial cancer: where are we now?

By Angioli Roberto Miranda Andrea Aloisi Alessia Montera Roberto Capriglione Stella Cicco Nardone Carlo Terranova Corrado Plotti Francesco

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 881-887

Springer Publishing Company

Access to resources Recommend Favorite

Clinical overview of leukocyte adhesion and migration: where are we now?

By Marshall D. Haskard D.O.

Seminars in Immunology, Vol. 14, Iss. 2, 2002-04 ,pp. : 133-140

Academic Press

Access to resources Recommend Favorite